Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaginal reconstruction performed simultaneously with pelvic exenteration.

J S Berek, N F Hacker, L D Lagasse

    Obstetrics and Gynecology
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.

    Oncogenesis·2022
    Same author

    Safety and dose modification for patients receiving niraparib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Safety and dose modification for patients receiving niraparib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Cytoreductive surgery for ovarian cancer: quality assessment.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.

    Translational oncology·2017
    Same author

    Impact of the 2014 FDA Warnings Against Laparoscopic Power Morcellation.

    Journal of minimally invasive gynecology·2016

    Vaginal reconstruction after pelvic exenteration for recurrent malignancy achieved an 86% success rate for neovagina creation using myocutaneous or skin grafts. Gracilis myocutaneous grafts were most feasible for total pelvic exenteration.

    Area of Science:

    • Surgical Oncology
    • Reconstructive Surgery
    • Gynecologic Oncology

    Background:

    • Pelvic exenteration is a radical surgical procedure for advanced pelvic malignancies.
    • Vaginal reconstruction is often necessary following pelvic exenteration to maintain function and quality of life.
    • Grafting techniques are crucial for successful neovagina creation.

    Purpose of the Study:

    • To evaluate the outcomes of vaginal reconstruction performed simultaneously with pelvic exenteration for recurrent pelvic malignancy.
    • To compare the efficacy of different grafting methods for neovagina creation.

    Main Methods:

    • Twenty-eight patients with recurrent pelvic malignancy underwent simultaneous vaginal reconstruction and pelvic exenteration.
    • Gracilis myocutaneous grafts were used in 21 patients.

    Related Experiment Videos

  • Split-thickness skin grafts, often combined with omental pedicle grafts, were used in seven patients.

    • Main Results:

    • A satisfactory neovagina was achieved in 24 (86%) patients.
    • Successful bilateral grafting was accomplished in 18 of 21 (86%) patients using gracilis myocutaneous grafts.
    • Six of seven patients (86%) using split-thickness skin grafts had a satisfactory neovagina.
    • No bowel herniation or fistulas were observed in the absence of recurrent malignancy.

    Conclusions:

    • Simultaneous vaginal reconstruction with pelvic exenteration yields high rates of satisfactory neovagina creation.
    • Gracilis myocutaneous grafts are suitable for total pelvic exenteration.
    • Split-thickness grafts are preferable for anterior exenteration or specific rectosigmoid reconstructions.